Literature DB >> 18789610

Early age at first childbirth associated with advanced tumor grade in breast cancer.

Carmela Veneroso1, Robert Siegel, Paul H Levine.   

Abstract

BACKGROUND: Many studies have investigated risk factors for developing breast cancer, but few have explored whether these risk factors are associated with the aggressiveness of the tumor. This case-case study examined the relationship between risk factors for breast cancer and the histological grade of the tumor at diagnosis, an important indicator of breast cancer aggressiveness.
METHODS: We interviewed 215 breast cancer patients and obtained information on their demographics, reproductive history and hormone use. Grade of tumor was obtained from a review of the patients' pathological reports. The relationships between tumor aggressiveness (classified by tumor grade) and risk factors of interest were analyzed using multi-variable logistic regression. Maximum likelihood estimates of the odds ratio were obtained and 95% confidence intervals (CI) were calculated.
RESULTS: In multivariable analyses we found that when comparing women who had their first child before age 20 with those who had their first child age 20 and older, women who had their first child before age 20 had approximately a 3.2 increased odds of having a higher-grade tumor (OR=3.20; 95% CI=1.20, 8.49). Long-term use of oral contraceptives, measured in years of oral contraceptive use, was also positively associated with a higher-grade tumor (OR=1.12; 95% CI=1.03-1.23). In addition we found that younger age at diagnosis was a strong predictor of a higher-grade tumor, with a 4% increased odds of having a higher-grade tumor for each year younger (OR=0.96; 95% CI=0.93-0.995).
CONCLUSIONS: Early age at first birth, long-term use of oral contraceptives, and younger age at diagnosis were associated with advanced tumor grade.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18789610     DOI: 10.1016/j.cdp.2008.04.001

Source DB:  PubMed          Journal:  Cancer Detect Prev        ISSN: 0361-090X


  6 in total

1.  Histological type and grade of breast cancer tumors by parity, age at birth, and time since birth: a register-based study in Norway.

Authors:  Grethe Albrektsen; Ivar Heuch; Steinar Ø Thoresen
Journal:  BMC Cancer       Date:  2010-05-21       Impact factor: 4.430

Review 2.  Association of Combined Estrogen-Progestogen and Progestogen-Only Contraceptives with the Development of Cancer.

Authors:  William V Williams; Louise A Mitchell; S Kathleen Carlson; Kathleen M Raviele
Journal:  Linacre Q       Date:  2019-01-03

3.  Clinicopathologic Factors Related to the Histological Tumor Grade of Breast Cancer in Western China: An Epidemiological Multicenter Study of 8619 Female Patients.

Authors:  Ke Zheng; Jin-Xiang Tan; Fan Li; Hong-Yuan Li; Xiao-Hua Zeng; Bin-Lin Ma; Jiang-Hua Ou; Hui Li; Sui-Sheng Yang; Ai-Mei Jiang; Qing Ni; Jian-Lun Liu; Jin-Ping Liu; Hong Zheng; Rui Ling; Jian-Jun He; Zhi-Gang Li; Jian Zeng; Tian-Ning Zou; Jun Jiang; Zhang-Jun Song; Qi-Lun Liu; Guo-Sheng Ren
Journal:  Transl Oncol       Date:  2018-07-03       Impact factor: 4.243

4.  Significant inter- and intra-laboratory variation in grading of invasive breast cancer: A nationwide study of 33,043 patients in the Netherlands.

Authors:  Carmen van Dooijeweert; Paul J van Diest; Stefan M Willems; Chantal C H J Kuijpers; Elsken van der Wall; Lucy I H Overbeek; Ivette A G Deckers
Journal:  Int J Cancer       Date:  2019-04-29       Impact factor: 7.396

5.  What is inflammatory breast cancer? Revisiting the case definition.

Authors:  Paul H Levine; Ladan Zolfaghari; Heather Young; Muhannad Hafi; Timothy Cannon; Chitra Ganesan; Carmela Veneroso; Rachel Brem; Mark Sherman
Journal:  Cancers (Basel)       Date:  2010-03-03       Impact factor: 6.639

6.  Importance of hereditary and selected environmental risk factors in the etiology of inflammatory breast cancer: a case-comparison study.

Authors:  Roxana Moslehi; Elizabeth Freedman; Nur Zeinomar; Carmela Veneroso; Paul H Levine
Journal:  BMC Cancer       Date:  2016-05-26       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.